1.58
price down icon3.66%   -0.06
after-market After Hours: 1.58
loading

Erasca Inc Stock (ERAS) Latest News

pulisher
Feb 10, 2025

Investor’s Toolkit: Key Ratios for Assessing Erasca Inc (ERAS)’s Performance - The Dwinnex

Feb 10, 2025
pulisher
Feb 07, 2025

Erasca Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle

Feb 07, 2025
pulisher
Feb 07, 2025

Erasca Inc [ERAS] Records 200-Day SMA of $2.5522 - Knox Daily

Feb 07, 2025
pulisher
Feb 06, 2025

Pyxis Oncology Inc [PYXS] stock for 174,364 USD was acquired by Connealy Pamela Ann - Knox Daily

Feb 06, 2025
pulisher
Feb 04, 2025

Metric Deep Dive: Understanding Erasca Inc (ERAS) Through its Ratios - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Erasca Inc (ERAS) is a good investment, but the stock may be undervalued - US Post News

Feb 04, 2025
pulisher
Feb 03, 2025

Erasca (NASDAQ:ERAS) Trading Up 6.6%Time to Buy? - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

Erasca (NASDAQ:ERAS) Stock Price Down 6.1%Time to Sell? - MarketBeat

Feb 03, 2025
pulisher
Jan 31, 2025

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference - The Manila Times

Jan 31, 2025
pulisher
Jan 31, 2025

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire Inc.

Jan 31, 2025
pulisher
Jan 28, 2025

Erasca: Future 'Streamlined' But Still Uncertain (NASDAQ:ERAS) - Seeking Alpha

Jan 28, 2025
pulisher
Jan 27, 2025

Erasca’s Naporafenib Is Shaping Up Nicely For NRASm Melanoma (NASDAQ:ERAS) - Seeking Alpha

Jan 27, 2025
pulisher
Jan 22, 2025

Down -25.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS) - MSN

Jan 22, 2025
pulisher
Jan 21, 2025

Erasca (NASDAQ:ERAS) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Jan 21, 2025
pulisher
Jan 20, 2025

Down -27.17% in 4 Weeks, Here's Why Erasca (ERAS) Looks Ripe for a Turnaround - MSN

Jan 20, 2025
pulisher
Jan 17, 2025

Down -24.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS) - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

Down -22.89% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS) - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

Erasca (NASDAQ:ERAS) Stock Price Down 6.2%Here's What Happened - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

JPMorgan Chase & Co. Sells 13,100 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Jan 17, 2025
pulisher
Jan 15, 2025

Erasca, Inc. (NASDAQ:ERAS) Shares Acquired by Barclays PLC - Defense World

Jan 15, 2025
pulisher
Jan 13, 2025

Erasca Highlights Strategic Focus at Healthcare Conference - TipRanks

Jan 13, 2025
pulisher
Jan 13, 2025

Jane Street Group LLC Trims Stock Position in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Jan 13, 2025
pulisher
Jan 10, 2025

Erasca (NASDAQ:ERAS) Trading Down 8.7%What's Next? - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Erasca (NASDAQ:ERAS) Upgraded at Bank of America - Defense World

Jan 10, 2025
pulisher
Jan 08, 2025

Erasca (NASDAQ:ERAS) Shares Up 3%Still a Buy? - MarketBeat

Jan 08, 2025
pulisher
Jan 08, 2025

Erasca, Inc. (NASDAQ:ERAS) Shares Sold by Principal Financial Group Inc. - Defense World

Jan 08, 2025
pulisher
Jan 07, 2025

Erasca (NASDAQ:ERAS) Rating Increased to Buy at Bank of America - MarketBeat

Jan 07, 2025
pulisher
Jan 07, 2025

Erasca (NASDAQ:ERAS) Shares Gap UpWhat's Next? - MarketBeat

Jan 07, 2025
pulisher
Jan 07, 2025

Erasca to Present at J.P. Morgan Healthcare Conference 2025: RAS/MAPK Cancer Innovations - StockTitan

Jan 07, 2025
pulisher
Jan 03, 2025

Franklin Resources Inc. Invests $181,000 in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Jan 03, 2025
pulisher
Jan 02, 2025

Erasca (NASDAQ:ERAS) Trading Up 7.6%Should You Buy? - MarketBeat

Jan 02, 2025
pulisher
Jan 01, 2025

Geode Capital Management LLC Raises Stock Position in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Geode Capital Management LLC Has $12.30 Million Position in Erasca, Inc. (NASDAQ:ERAS) - MarketBeat

Jan 01, 2025
pulisher
Dec 31, 2024

Barclays PLC Increases Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Dec 31, 2024
pulisher
Dec 26, 2024

Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment - ShareCast

Dec 26, 2024
pulisher
Dec 25, 2024

State Street Corp Acquires 3,569,440 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Dec 25, 2024
pulisher
Dec 25, 2024

Erasca, Inc. (NASDAQ:ERAS) Shares Purchased by State Street Corp - MarketBeat

Dec 25, 2024
pulisher
Dec 19, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires New Stake in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Dec 19, 2024
pulisher
Dec 19, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Invests $994,000 in Erasca, Inc. (NASDAQ:ERAS) - MarketBeat

Dec 19, 2024
pulisher
Dec 18, 2024

Fmr LLC Boosts Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Dec 18, 2024
pulisher
Dec 17, 2024

The Manufacturers Life Insurance Company Increases Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

KRAS Inhibitors Market Top Companies StudyAmgen, Boehringer - openPR

Dec 17, 2024
pulisher
Dec 14, 2024

Erasca, Inc. (NASDAQ:ERAS) Shares Sold by Point72 Asset Management L.P. - MarketBeat

Dec 14, 2024
pulisher
Dec 14, 2024

Charles Schwab Investment Management Inc. Purchases 390,209 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Dec 14, 2024
pulisher
Dec 14, 2024

Erasca, Inc. (NASDAQ:ERAS) Stock Position Raised by Charles Schwab Investment Management Inc. - MarketBeat

Dec 14, 2024
pulisher
Dec 12, 2024

Clear Street starts Erasca with Buy, sets $5 price target By Investing.com - Investing.com UK

Dec 12, 2024
$79.89
price up icon 2.27%
$32.25
price up icon 1.67%
$4.47
price down icon 5.10%
$353.31
price up icon 2.22%
biotechnology ONC
$221.22
price up icon 0.71%
$114.50
price down icon 0.67%
Cap:     |  Volume (24h):